Printer Friendly

i"?Natera signs distribution agreement with Echevarne.

M2 EQUITYBITES-May 17, 2013-i" Natera signs distribution agreement with Echevarne(C)2013 M2 COMMUNICATIONS http://www.m2.com

Natera, a San Carlos-based genetic testing company, has signed a distribution agreement with Echevarne, a European laboratory, it was reported yesterday.

According to the contract, Echevarne will provide Natera's non-invasive prenatal screening test, Panorama, in Spain. The product was introduced in March 2013 for the detection of trisomy 21, trisomy 18, trisomy 13 and certain sex chromosome abnormalities, such as monosomy X.

Echevarne CEO, Alfonso Echevarne, stated that the test is the new option for parents and their doctors who want highly accurate information with no risk for the foetus. The test can be conducted within the first trimester of pregnancy, as early as nine weeks, without any risk to the foetus.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:May 17, 2013
Words:141
Previous Article:Cardinal Bank announces promotion of Hilary J Blackburn as SVP of Marketing Product Manager.
Next Article:B&G Foods announces quarterly dividend of USD0.29 per share.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters